Menu
Recruiting NCT07608653

Outcomes of Laparoscopic Keyhole Surgery (TAPP) for Recurrent Inguinal Hernia

No phase Interventional Recurrant Inguinal Hernia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Laparoscopic Transabdominal Preperitoneal (TAPP) Repair.
Who it may be relevant to
Registry conditions: Recurrant Inguinal Hernia. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Outcomes of Laparoscopic Transabdominal Preperitoneal (TAPP) Approach for Recurrent Inguinal Hernia

Overview

The goal of this clinical trial is to learn if a laparoscopic surgery called Transabdominal Preperitoneal (TAPP) repair is safe and works well for adults with a recurrent inguinal hernia (a groin hernia that has returned after a previous operation). The main questions it aims to answer are: Does the TAPP technique lower the number of complications after surgery? How well do participants recover during the early postoperative period and long-term follow-up? Fixing a hernia that has returned is hard because of old scar tissue. In this study, researchers will use the TAPP technique to work through a different layer of tissue to provide a stronger repair. Participants will: Undergo the TAPP laparoscopic surgery for their recurrent hernia. Visit the clinic for close health monitoring shortly after surgery. Complete regular follow-up checkups to track their long-term recovery.

Interventions

  • Procedure Laparoscopic Transabdominal Preperitoneal (TAPP) Repair
    The surgical procedure will be performed under general anesthesia. Standard laparoscopic instruments will be used to access the peritoneal cavity. The peritoneum over the recurrent inguinal hernia site will be incised to enter the preperitoneal space. After reduction of the hernia sac and clearing of post-operative adhesions, a synthetic mesh will be placed to cover the hernia defects. The mesh will be secured if necessary, and the peritoneal flap will be closed using sutures or tacks.

Primary outcome measures

  • Feasibility and Technical Success of Laparoscopic TAPP [Time frame: During the intraoperative procedure (Day of surgery)]
Secondary outcome measures (7)
  • Post-operative Pain [Time frame: At 24 hours, 1 week, and 1 month post-operatively]
  • Hernia Recurrence [Time frame: 4 months]
  • Operative Time [Time frame: During the surgical procedure (Day of surgery)]
  • Length of Hospital Stay [Time frame: From the day of surgery up to hospital discharge (typically 1-2 days)]
  • Incidence of Post-operative Complications [Time frame: Up to 4 months post-operatively]
  • Incidence of Intraoperative Complications [Time frame: During the surgical procedure (Day of surgery)]
  • Time to Return to Normal Daily Activities [Time frame: Up to 4 months post-operatively]

Eligibility criteria

Inclusion criteria

  • Adult patients. Patients diagnosed with recurrent inguinal hernia. Patients fit for general anesthesia. Patients who provide informed consent.

Exclusion criteria

  • Non recurrent inguinal hernia Patients with complicated inguinal hernia. Patients unfit for general anesthesia. Patients refusing participation in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Faculty of medicine — Sohag

Identifiers

NCT: NCT07608653 · Soh-Med-26-5-3MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗